Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Qiming Wu
Observed institution:
Shantou University Medical College
ORCID:
0000-0002-8933-5063
Observed ORCID:
0000-0002-8933-5063
OpenAlex ID:
A5016206743
Nifuroxazide Activates the Parthanatos to Overcome TMPRSS2:ERG Fusion-Positive Prostate Cancer
2023
·
Chengxun Li
, Jiale Zhang
, et al.
·
Molecular Cancer Therapeutics
·
13
PDF
Supplementary Materials from Nifuroxazide Activates the Parthanatos to Overcome TMPRSS2:ERG Fusion-Positive Prostate Cancer
2025
·
Chengxun Li
, Jiale Zhang
, et al.
PDF
Supplementary Data 1 from Nifuroxazide Activates the Parthanatos to Overcome TMPRSS2:ERG Fusion-Positive Prostate Cancer
2025
·
Chengxun Li
, Jiale Zhang
, et al.
Data from Nifuroxazide Activates the Parthanatos to Overcome TMPRSS2:ERG Fusion-Positive Prostate Cancer
2024
·
Chengxun Li
, Jiale Zhang
, et al.
Supplementary Materials from Nifuroxazide Activates the Parthanatos to Overcome TMPRSS2:ERG Fusion-Positive Prostate Cancer
2023
·
Chengxun Li
, Jiale Zhang
, et al.
PDF
Supplementary Data 1 from Nifuroxazide Activates the Parthanatos to Overcome TMPRSS2:ERG Fusion-Positive Prostate Cancer
2023
·
Chengxun Li
, Jiale Zhang
, et al.
Data from Nifuroxazide Activates the Parthanatos to Overcome TMPRSS2:ERG Fusion-Positive Prostate Cancer
2023
·
Chengxun Li
, Jiale Zhang
, et al.
Show more works
View as search
Works count:
7
Citation count:
13
H-index:
1
I10-index:
1
Year
Topic
Type
